Biogen Spends $350 Million to Develop Gene Therapies For Alzheimer’s, Parkinson’s
By
Phil Gutis
| March 3rd, 2020
Frustrated for decades with failure after failure in efforts to find effective medications to treat Alzheimer’s and other cognitive disorders, researchers are now increasingly…